Kubota Pharmaceutical Holdings Co., Ltd.

KBBTFOTCHealthcare

$0.96

+$0.00(+0.00%)

Market Cap$24097728

P/E Ratio—

52W High$2.81

52W Low$0.96

Avg Volume3

Open$0.96

Beta1.18

Earnings Financials Revenue

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

KBBTF · earnings · updated Jun 8, 2026

Latest Earnings

Q1 FY2023Report Date: Feb 14, 2023

EPS Actual

-$6.23

Revenue

—

Fiscal Period

Q1 FY2023

FY ends December

Report Date

Feb 14, 2023

After Market Close

KBBTF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $0.58B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$0.58B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2023	Feb 14, 2023	—	-$6.23	—	—	—	—
— Q4 FY2022	Nov 11, 2022	—	-$9.44	—	—	—	—
— Q3 FY2022	Aug 12, 2022	—	-$11.73	—	—	—	—
— Q2 FY2022	May 13, 2022	—	-$14.30	—	—	—	—
— Q4 FY2021	Nov 12, 2021	—	-$12.65	—	—	—	—
— Q3 FY2021	Aug 12, 2021	—	-$14.39	—	—	—	—
— Q2 FY2021	May 13, 2021	—	-$15.48	—	—	—	—
— Q1 FY2021	Feb 12, 2021	—	-$12.84	—	—	—	—

Q1 FY2023

Feb 14, 2023

EPS Actual

-$6.23

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2022

Nov 11, 2022

EPS Actual

-$9.44

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2022

Aug 12, 2022

EPS Actual

-$11.73

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2022

May 13, 2022

EPS Actual

-$14.30

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2021

Nov 12, 2021

EPS Actual

-$12.65

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2021

Aug 12, 2021

EPS Actual

-$14.39

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2021

May 13, 2021

EPS Actual

-$15.48

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2021

Feb 12, 2021

EPS Actual

-$12.84

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for KBBTF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2023	Feb 14, 2023	—	$0.96	—	—
— Q4 FY2022	Nov 11, 2022	—	$1.85	$0.95	-48.65%
— Q3 FY2022	Aug 12, 2022	—	$1.85	$0.95	-48.65%
— Q2 FY2022	May 13, 2022	—	$1.80	$1.95	+8.33%
— Q4 FY2021	Nov 12, 2021	—	$1.80	$1.80	+0.00%
— Q3 FY2021	Aug 12, 2021	—	$2.04	$2.04	+0.00%
— Q2 FY2021	May 13, 2021	—	$2.42	$2.42	+0.00%
— Q1 FY2021	Feb 12, 2021	—	$2.66	$2.66	+0.00%

Q1 FY2023—

Report Date

Feb 14, 2023

EPS Beat/Miss

—

Price Before

$0.96

Price After

—

Q4 FY2022-48.65%

Report Date

Nov 11, 2022

EPS Beat/Miss

—

Price Before

$1.85

Price After

$0.95

Q3 FY2022-48.65%

Report Date

Aug 12, 2022

EPS Beat/Miss

—

Price Before

$1.85

Price After

$0.95

Q2 FY2022+8.33%

Report Date

May 13, 2022

EPS Beat/Miss

—

Price Before

$1.80

Price After

$1.95

Q4 FY2021+0.00%

Report Date

Nov 12, 2021

EPS Beat/Miss

—

Price Before

$1.80

Price After

$1.80

Q3 FY2021+0.00%

Report Date

Aug 12, 2021

EPS Beat/Miss

—

Price Before

$2.04

Price After

$2.04

Q2 FY2021+0.00%

Report Date

May 13, 2021

EPS Beat/Miss

—

Price Before

$2.42

Price After

$2.42

Q1 FY2021+0.00%

Report Date

Feb 12, 2021

EPS Beat/Miss

—

Price Before

$2.66

Price After

$2.66

Beat Rate0 / 8 quarters

Largest Move-48.65% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) most recently reported earnings on February 14, 2023 for Q1 FY2023, posting EPS of $-6.23 (in line with the analyst consensus of —). The next KBBTF earnings date is expected around September 1, 2026.

Each quarter, investors track KBBTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KBBTF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

KBBTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

KBBTF earnings · 4 questions

Kubota Pharmaceutical Holdings Co., Ltd.'s next earnings report is expected around September 1, 2026. KBBTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KBBTF historically reports after market close (AMC).

KBBTF earnings datewhen is KBBTF earningsKBBTF next earnings datewhen does KBBTF report earningsKBBTF earnings calendar

▸ Source: FMP · Kubota Pharmaceutical Holdings Co., Ltd. SEC filings · US GAAP · Kubota Pharmaceutical Holdings Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026